FindTrial
Sign In

Significance of intraglandular periparotid occult and overt cervical lymphnode metastasis in primary parotid cancer

Prospective study to determine the incidence of intraglandular,peri-parotid,occult and overt cervical lymph node metastasis in patients with primary parotid carcinomas

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027779
Enrollment
50
Registered
2020-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C07- Malignant neoplasm of parotid gland

Interventions

None listed

Sponsors

Department of otorhinolaryngology and Head Neck surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All cases of FNAC/core biopsy proven primary parotid carcinomas planned for total conservative parotidectomy or radical parotidectomy 2. Patient giving consent to participate in study.

Exclusion criteria

Exclusion criteria: 1. Patient who is not willing to participate in the study 2. Patient is unfit for surgery under general anesthesia 3. Severe claustrophobia. 4. H/o anaphylactoid reactions with intravenous contrast for MRI 5. Benign salivary gland tumors

Design outcomes

Primary

MeasureTime frame
High incidence of intraglandular lymph node in patient high grade primary parotid tumor with occult cervical lymphnodeTimepoint: At base line, 4 weeks, 8 weeks—

Secondary

MeasureTime frame
CEMRI AND USG ARE ABLE TO FIND OUT LYMPHNODE METATSTASES PRE OPERATIVELYTimepoint: At base line—

Countries

India

Contacts

Public ContactShijitha P

All India Institute Of Medical Sciences, New Delhi

rajeev9843@yahoo.co.in8098294726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026